191 related articles for article (PubMed ID: 35059994)
1. Advances in Molecular Profiling and Developing Clinical Trials of CNS Germ Cell Tumors: Present and Future Directions.
Takami H
Curr Oncol Rep; 2022 Jan; 24(1):105-112. PubMed ID: 35059994
[TBL] [Abstract][Full Text] [Related]
2. Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy.
Ichimura K; Fukushima S; Totoki Y; Matsushita Y; Otsuka A; Tomiyama A; Niwa T; Takami H; Nakamura T; Suzuki T; Fukuoka K; Yanagisawa T; Mishima K; Nakazato Y; Hosoda F; Narita Y; Shibui S; Yoshida A; Mukasa A; Saito N; Kumabe T; Kanamori M; Tominaga T; Kobayashi K; Shimizu S; Nagane M; Iuchi T; Mizoguchi M; Yoshimoto K; Tamura K; Maehara T; Sugiyama K; Nakada M; Sakai K; Kanemura Y; Nonaka M; Asai A; Yokogami K; Takeshima H; Kawahara N; Takayama T; Yao M; Kato M; Nakamura H; Hama N; Sakai R; Ushijima T; Matsutani M; Shibata T; Nishikawa R;
Acta Neuropathol; 2016 Jun; 131(6):889-901. PubMed ID: 26956871
[TBL] [Abstract][Full Text] [Related]
3. [Evolving Exploration of the Pathogenesis of CNS Germ Cell Tumors with Regard to Precision Medicine].
Takami H; Takayanagi S; Tanaka S; Saito N
No Shinkei Geka; 2022 Jan; 50(1):39-50. PubMed ID: 35169085
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterparts.
Takami H; Elzawahry A; Mamatjan Y; Fukushima S; Fukuoka K; Suzuki T; Yanagisawa T; Matsushita Y; Nakamura T; Satomi K; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Tamura K; Maehara T; Sugiyama K; Yoshimoto K; Sakai K; Nonaka M; Asai A; Yokogami K; Takeshima H; Narita Y; Shibui S; Nakazato Y; Hama N; Totoki Y; Kato M; Shibata T; Nishikawa R; Matsutani M; Ichimura K
Neuro Oncol; 2022 Aug; 24(8):1246-1258. PubMed ID: 35137206
[TBL] [Abstract][Full Text] [Related]
5. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.
Satomi K; Takami H; Fukushima S; Yamashita S; Matsushita Y; Nakazato Y; Suzuki T; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Yoshimoto K; Tamura K; Maehara T; Sakai K; Sugiyama K; Yokogami K; Takeshima H; Nonaka M; Asai A; Ushijima T; Matsutani M; Nishikawa R; Ichimura K
Neuro Oncol; 2022 May; 24(5):834-846. PubMed ID: 34698864
[TBL] [Abstract][Full Text] [Related]
6. Impact of tumor markers on diagnosis, treatment and prognosis in CNS germ cell tumors: correlations with clinical practice and histopathology.
Takami H; Graffeo CS; Perry A; Giannini C; Nakazato Y; Saito N; Matsutani M; Nishikawa R; Daniels DJ; Ichimura K
Brain Tumor Pathol; 2023 Apr; 40(2):124-132. PubMed ID: 36995447
[TBL] [Abstract][Full Text] [Related]
7. Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT Consortium.
Takami H; Fukuoka K; Fukushima S; Nakamura T; Mukasa A; Saito N; Yanagisawa T; Nakamura H; Sugiyama K; Kanamori M; Tominaga T; Maehara T; Nakada M; Kanemura Y; Asai A; Takeshima H; Hirose Y; Iuchi T; Nagane M; Yoshimoto K; Matsumura A; Kurozumi K; Nakase H; Sakai K; Tokuyama T; Shibui S; Nakazato Y; Narita Y; Nishikawa R; Matsutani M; Ichimura K
Neuro Oncol; 2019 Dec; 21(12):1565-1577. PubMed ID: 31420671
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers for risk-based treatment modifications for CNS germ cell tumors: Updates on biological underpinnings, clinical trials, and future directions.
Takami H; Ichimura K
Front Oncol; 2022; 12():982608. PubMed ID: 36132131
[TBL] [Abstract][Full Text] [Related]
9. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
Khatua S; Dhall G; O'Neil S; Jubran R; Villablanca JG; Marachelian A; Nastia A; Lavey R; Olch AJ; Gonzalez I; Gilles F; Nelson M; Panigrahy A; McComb G; Krieger M; Fan J; Sposto R; Finlay JL
Pediatr Blood Cancer; 2010 Jul; 55(1):42-6. PubMed ID: 20222020
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas.
Fukushima S; Yamashita S; Kobayashi H; Takami H; Fukuoka K; Nakamura T; Yamasaki K; Matsushita Y; Nakamura H; Totoki Y; Kato M; Suzuki T; Mishima K; Yanagisawa T; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Nagane M; Iuchi T; Yoshimoto K; Mizoguchi M; Tamura K; Sakai K; Sugiyama K; Nakada M; Yokogami K; Takeshima H; Kanemura Y; Matsuda M; Matsumura A; Kurozumi K; Ueki K; Nonaka M; Asai A; Kawahara N; Hirose Y; Takayama T; Nakazato Y; Narita Y; Shibata T; Matsutani M; Ushijima T; Nishikawa R; Ichimura K;
Acta Neuropathol; 2017 Mar; 133(3):445-462. PubMed ID: 28078450
[TBL] [Abstract][Full Text] [Related]
11. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy.
Murray MJ; Bailey S; Heinemann K; Mann J; Göbel UK; Saran F; Hale JP; Calaminus G; Nicholson JC
Int J Cancer; 2017 Aug; 141(3):621-635. PubMed ID: 28463397
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and immunohistochemical features of primary central nervous system germ cell tumors: a 24-years experience.
Gao Y; Jiang J; Liu Q
Int J Clin Exp Pathol; 2014; 7(10):6965-72. PubMed ID: 25400782
[TBL] [Abstract][Full Text] [Related]
13. Multimodality treatment for Central Nervous System Germ Cell Tumors: Disease spectrum and management strategies - A tertiary care center experience from India.
Kumar N; Madan R; Dracham CB; Khosla D; Das N; Dey T; Elangovan A; Tripathi M; Gupta K; Ahuja CK; Kapoor R
Clin Neurol Neurosurg; 2021 Mar; 202():106481. PubMed ID: 33508649
[TBL] [Abstract][Full Text] [Related]
14. Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sGCT).
Calaminus G; Andreussi L; Garré ML; Kortmann RD; Schober R; Göbel U
Klin Padiatr; 1997; 209(4):222-7. PubMed ID: 9293454
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.
Takada A; Ii N; Hirayama M; Toyoda H; Matsubara T; Toyomasu Y; Kawamura T; Daimon T; Sakuma H; Nomoto Y
J Neurosurg Pediatr; 2018 Nov; 23(3):317-324. PubMed ID: 30497152
[TBL] [Abstract][Full Text] [Related]
16. Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma.
Mishima K; Kato Y; Kaneko MK; Nakazawa Y; Kunita A; Fujita N; Tsuruo T; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 Jun; 111(6):563-8. PubMed ID: 16718353
[TBL] [Abstract][Full Text] [Related]
17. Multi-institutional analysis of central nervous system germ cell tumors in patients with Down syndrome.
Harris MK; Graham RT; Cappellano AM; Margol AS; Michaiel G; Crawford JR; Ioakeim-Ioannidou M; Stanek JR; Liu KX; MacDonald SM; Abdelbaki MS
Pediatr Blood Cancer; 2022 Oct; 69(10):e29830. PubMed ID: 35686831
[TBL] [Abstract][Full Text] [Related]
18. Advances in genetic abnormalities, epigenetic reprogramming, and immune landscape of intracranial germ cell tumors.
Zhang Y; Zhong C; Ke X; Liu J; Ye Z; Lu L; Deng K; Zhu H; Yao Y
Acta Neuropathol Commun; 2023 Nov; 11(1):188. PubMed ID: 38012690
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic analysis of central nervous system germ cell tumors with comparative genomic hybridization.
Schneider DT; Zahn S; Sievers S; Alemazkour K; Reifenberger G; Wiestler OD; Calaminus G; Göbel U; Perlman EJ
Mod Pathol; 2006 Jun; 19(6):864-73. PubMed ID: 16607373
[TBL] [Abstract][Full Text] [Related]
20. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.
Liu APY; Dhanda SK; Lin T; Sioson E; Vasilyeva A; Gudenas B; Tatevossian RG; Jia S; Neale G; Bowers DC; Hassall T; Partap S; Crawford JR; Chintagumpala M; Bouffet E; McCowage G; Broniscer A; Qaddoumi I; Armstrong G; Wright KD; Upadhyaya SA; Vinitsky A; Tinkle CL; Lucas J; Chiang J; Indelicato DJ; Sanders R; Klimo P; Boop FA; Merchant TE; Ellison DW; Northcott PA; Orr BA; Zhou X; Onar-Thomas A; Gajjar A; Robinson GW
Acta Neuropathol; 2022 Oct; 144(4):733-746. PubMed ID: 35982322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
